GILEAD SCIENCES INC
GILD·375558103·US·Common Stock·Healthcare - Drug Manufacturers - General-13D/G
GILD (GILEAD SCIENCES INC) is held by 362 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($15.4B), VANGUARD CAPITAL MANAGEMENT LLC ($10.2B), FMR LLC ($8.4B). Net institutional sentiment: Mixed. In Q2 2026, 8 members of Congress and 183 funds bought GILD.
362
Holders
(35 Elite)
$131B
Total Value
51% (361)
Consensus
183 buying - 178 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 16, 2026 · Insiders Oct 16, 2026 · Activists Apr 29, 2026 · Congress Aug 5, 2026
InsiderMJMercier JohannaSell $469KOct 15, 2026
InsiderDDDickinson Andrew DSell $469KOct 15, 2026
InsiderOPO'Day Daniel PatrickSell $1.8MOct 1, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 370
1 / 19
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer